共 7 条
[1]
[2]
[3]
[4]
Risk factors for acute esophagitis in non–small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.[J].Xiong Wei;H. Helen Liu;Susan L. Tucker;Zhongxing Liao;Chaosu Hu;Radhe Mohan;James D. Cox;Ritsuko Komaki.International Journal of Radiation Oncology; Biology; Physics.2006, 1
[5]
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trial.[J].Ritsuko Komaki;Jin Soo Lee;Luka Milas;Hoon K Lee;Frank V Fossella;Roy S Herbst;Pamela K Allen;Zhongxing Liao;Craig W Stevens;Charles Lu;Ralph G Zinner;Vassiliki A Papadimitrakopoulou;Merrill S Kies;George R Blumenschein;Katherine M Pisters;Bonnie S Glisson;Johnathan Kurie;Bunyamin Kaplan;Veronica P Garza;Deidre Mooring;Susan
[6]
Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2001, 51 (04)
:915-922
[7]
Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival.[J].Maria Werner-Wasik;Charles Scott;James D Cox;William T Sause;Roger W Byhardt;Sucha Asbell;Anthony Russell;Ritsuko Komaki;Jin Soo Lee.International Journal of Radiation Oncology; Biology; Physics.2000, 5

